Sort
23,748 grants matching “melanoma”
ROLE OF THE INHIBITORY RECEPTOR TIGIT IN THE REGULATION OF CD4+ TREGS IN PATIENTS WITH ADVANCED MELANOMA
$551,252University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2015 · Department of the Army
CCR DNA Sequencing MiniCore
$551,172Kathleen Hartman · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk
$551,100Joel J Hillhouse · East Tennessee State University · R01 · FY2012 · CA
Cell type-directed Tim-3 targeting in melanoma
$551,025Steven Russell Barthel · Brigham And Women'S Hospital · R01 · FY2024 · CA
Systems analysis of cell-cell communication networks and immune activity in the melanoma tumor microenvironment
$551,007Kathryn Miller-Jensen · Yale University · U01 · FY2022 · CA
Congenic Mouse Medels of Melanoma for the Characterization of Tumor Immune Responses
$550,926Marcus W Bosenberg · Yale University · R01 · FY2016 · CA
Intrinsic and Extrinsic factors regulating competition for active TGFb promote skin memory CD8 T cell fitness
$550,909Daniel H Kaplan · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AR
Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis
$550,845Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer
$550,839Michelle S Bradbury · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Peri-operative confocal imaging-guided laser ablation of basal cell carcinomas
$550,785Milind Rajadhyaksha · Sloan-Kettering Inst Can Research · R01 · FY2017 · EB
Impact of Melanoma Genetic Testing on Health Cognitions and Prevention Behaviors
$550,757Sancy Ann Leachman · University Of Utah · R01 · FY2013 · CA
Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy
$550,644Jin-Ming Yang · University Of Kentucky · R01 · FY2023 · CA
Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy
$550,643Jin-Ming Yang · University Of Kentucky · R01 · FY2022 · CA
Role of progenitor exhausted CD8 T cells and the progenitor niche in anti-PD1 efficacy
$550,500Alexander Huang · University Of Pennsylvania · R01 · FY2023 · CA
Enhanced Development of the Xiphophorus Model System
$550,500Ronald Walter · Texas State University · R24 · FY2017 · OD
Next generation oncolytic virotherapy targeting AKT and ERK signaling in glioma
$550,350Balveen Kaur · Augusta University · R01 · FY2025 · NS
Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)
$550,328Mohamed H. Abdel-Rahman · Ohio State University · R01 · FY2023 · CA
Reprogramming the tumor microenvironment via self-amplified RNA (SafeR) circuits
$550,228Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2016 · CA
Reprogramming the tumor microenvironment via self-amplified RNA (SafeR) circuits
$550,228Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2020 · CA
Reprogramming the tumor microenvironment via self-amplified RNA (SafeR) circuits
$550,228Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2017 · CA
Reprogramming the tumor microenvironment via self-amplified RNA (SafeR) circuits
$550,228Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2018 · CA
Postmortem Pathology
$550,097David E Kleiner · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
A Human Intraepithelial Tumor Microenvironment Assay
$550,042Barbara Lynn Allen-Hoffmann · Stratatech Corporation · R42 · FY2011 · CA
Multi-peptide Vaccine Administered with Cyclophosphamide for High-risk Melanoma
$550,016Craig Lee Slingluff · University Of Virginia · R01 · FY2007 · CA
Senescence-on-a-chip: Building a microphysiological 3D skin model
$549,999Angela M Christiano · Columbia University Health Sciences · UG3 · FY2023 · CA